Andrew R Green Selected Research

Phenobarbital (Luminal)

12/2024	The amino acid transporter SLC7A11 expression in breast cancer.
12/2023	Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression.
9/2023	Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer.
1/2023	The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long-term follow-up.
12/2022	Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods.
10/2021	Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
9/2021	SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer.
8/2021	The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer.
9/2020	The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
6/2020	Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew R Green Research Topics

Disease

186	Breast Neoplasms (Breast Cancer) 12/2024 - 03/2005
119	Neoplasms (Cancer) 12/2024 - 10/2005
28	Neoplasm Metastasis (Metastasis) 11/2022 - 08/2008
22	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 09/2012
11	Carcinoma (Carcinomatosis) 01/2020 - 05/2009
10	Triple Negative Breast Neoplasms 12/2023 - 01/2007
10	Carcinogenesis 03/2023 - 02/2013
8	Breast Ductal Carcinoma 01/2022 - 12/2018
6	Disease Progression 11/2022 - 07/2011
6	Ductal Carcinoma 11/2022 - 01/2008
6	Necrosis 01/2020 - 01/2018
5	Genomic Instability 01/2021 - 01/2007
4	Lobular Carcinoma 11/2020 - 01/2008
3	Lymphatic Metastasis 09/2020 - 04/2017
3	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2019 - 12/2014
2	Inflammation (Inflammations) 01/2023 - 12/2015
2	Residual Neoplasm 11/2019 - 07/2016
2	Ovarian Neoplasms (Ovarian Cancer) 08/2013 - 07/2011
2	Prostatic Neoplasms (Prostate Cancer) 07/2011 - 01/2009
2	Breast Carcinoma In Situ 10/2010 - 03/2009

Drug/Important Bio-Agent (IBA)

96	Proteins (Proteins, Gene)FDA Link 12/2024 - 03/2006
44	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2007
37	Messenger RNA (mRNA)IBA 12/2024 - 01/2007
33	Estrogen ReceptorsIBA 11/2023 - 01/2007
32	Phenobarbital (Luminal)FDA Link 12/2024 - 01/2007
17	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 01/2007
15	Hormones (Hormone)IBA 11/2022 - 10/2007
11	human ERBB2 proteinIBA 12/2023 - 03/2010
9	Cadherins (E-Cadherin)IBA 01/2019 - 06/2006
8	Eosine Yellowish-(YS) (Eosin)IBA 12/2023 - 08/2010
8	Tamoxifen FDA LinkGeneric 09/2021 - 03/2005
8	Phosphotransferases (Kinase)IBA 07/2020 - 04/2012
8	Indicators and Reagents (Reagents)IBA 01/2019 - 03/2006
8	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2013
7	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2007
6	Estrogens (Estrogen)FDA Link 11/2022 - 01/2013
6	Glutamine (L-Glutamine)FDA Link 01/2021 - 01/2018
6	AnthracyclinesIBA 01/2020 - 11/2014
6	Trastuzumab (Herceptin)FDA Link 11/2019 - 04/2010
5	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2024 - 01/2018
5	Protein Isoforms (Isoforms)IBA 08/2021 - 08/2008
5	ErbB Receptors (EGF Receptor)IBA 07/2020 - 01/2007
5	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2017 - 07/2014
5	ParaffinIBA 01/2016 - 12/2007
4	Hematoxylin (Haematoxylon)IBA 12/2023 - 01/2018
4	Estrogen Receptor alphaIBA 11/2020 - 08/2008
4	CollagenIBA 10/2019 - 11/2007
4	AntibodiesIBA 12/2015 - 08/2008
3	RecQ HelicasesIBA 12/2023 - 03/2016
3	Keratins (Keratin)IBA 01/2023 - 05/2010
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2009
3	CytokinesIBA 01/2020 - 04/2018
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019 - 04/2015
3	MicroRNAs (MicroRNA)IBA 01/2013 - 01/2007
3	Steroid Receptors (Steroid Receptor)IBA 01/2010 - 08/2008
2	RANK LigandIBA 11/2023 - 01/2021
2	GlutaminaseIBA 08/2021 - 03/2020
2	Flap EndonucleasesIBA 07/2021 - 12/2014
2	DNA HelicasesIBA 01/2021 - 01/2021
2	TensinsIBA 07/2020 - 02/2011
2	MucinsIBA 07/2020 - 10/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020 - 01/2019
2	Large Neutral Amino Acid-Transporter 1IBA 02/2020 - 01/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 01/2015
2	olaparibIBA 01/2020 - 12/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 04/2018
2	taxaneIBA 08/2019 - 07/2016
2	Cyclin D1IBA 01/2019 - 05/2008
2	GTP-Binding Proteins (G-Protein)IBA 05/2018 - 04/2015
2	CalpainIBA 01/2017 - 10/2011
2	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 08/2016 - 04/2016
2	Serine (L-Serine)FDA Link 02/2016 - 03/2015
2	Formaldehyde (Formol)FDA Link 01/2016 - 01/2011
2	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2015 - 12/2013
2	DNA-Activated Protein KinaseIBA 12/2014 - 07/2014
2	Methotrexate (Mexate)FDA LinkGeneric 11/2014 - 04/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2014 - 04/2010
2	IntegrinsIBA 08/2014 - 06/2014
2	CateninsIBA 04/2013 - 10/2010
2	Monoclonal AntibodiesIBA 02/2013 - 05/2008
2	calpastatinIBA 10/2011 - 10/2011
2	Histones (Histone)IBA 08/2010 - 05/2009
2	LigandsIBA 04/2010 - 03/2006
2	Estrogen Receptor betaIBA 03/2009 - 12/2008
2	Keratin-5 (Keratin 5)IBA 10/2008 - 08/2008
1	Glutamic Acid (Glutamate)FDA Link 12/2024
1	Cysteine (L-Cysteine)FDA Link 12/2024
1	Denosumab FDA Link 11/2023
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 11/2023
1	Cyclin B1IBA 04/2023
1	Long Noncoding RNAIBA 03/2023

Therapy/Procedure

57	Therapeutics 12/2024 - 10/2005
16	Drug Therapy (Chemotherapy) 11/2023 - 04/2009
7	Radiotherapy 01/2020 - 12/2014
5	Adjuvant Chemotherapy 11/2019 - 04/2010
3	Segmental Mastectomy (Lumpectomy) 11/2021 - 04/2017
2	Neoadjuvant Therapy 02/2022 - 07/2016
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 01/2019
2	Ligation 05/2014 - 04/2014
2	Lasers (Laser) 01/2011 - 03/2009